Search Results for: colorado

Colorado Gov. Polis Grants Historic Pardons For Marijuana Convictions

COLORADO:Governor Jared Polis today signed an Executive Order granting pardons to those who have been convicted of possessing one ounce or less of marijuana. In June, Gov. Polis signed the bipartisan H.B. 20-1424, sponsored by Rep. James Coleman, Sen. Julie Gonzales and Sen. Vicki Marble, including an amendment sponsored by Sen. Gonzales, which authorizes the Governor to grant pardons to a class of defendants who were convicted of the possession of up to two ounces of marijuana. Reps. Leslie Herod and Jonathan Singer were also champions of passing this legislation. The new law went into effect this month.

“We are finally cleaning up some of the inequities of the past by pardoning 2,732 convictions for Coloradans who simply had an ounce of marijuana or less. It’s ridiculous how being written up for smoking a joint in the 1970’s has followed some Coloradans throughout their lives and gotten in the way of their success,” said Governor Jared Polis. “Too many Coloradans have been followed their entire lives by a conviction for something that is no longer a crime, and these convictions have impacted their job status, housing, and countless other areas of their lives. Today we are taking this step toward creating a more just system and breaking down barriers to help transform people’s lives as well as coming to terms with one aspect of the past, failed policy of marijuana prohibition.”

This pardon applies to state-level convictions of possession for one ounce or less of marijuana, as identified by the Colorado Bureau of Investigation (CBI).  Under H.B. 20-1424, the Governor is granting pardons for a class of people with convictions for possession of one ounce or less of marijuana. The individuals who have these convictions did not need to apply for pardons, and the Governor’s Office has not conducted individual assessments of the people who have been pardoned through this process. Individuals convicted of municipal marijuana crimes, or individuals arrested or issued a summons without a conviction, are not included in the pardons.

Individuals who are unsure whether a conviction on their record has been pardoned may fill out a form to request confirmation of a pardon on the Colorado Bureau of Investigations website. To obtain their entire criminal history, people can visit CBIRecordsCheck.com. Once a conviction is pardoned, it will not appear on a criminal history obtained on the records check website.

For further questions visit the FAQ document.

Visit COMarijuanaPardons.com for more information.

Colorado Senator Gardner Calls On USDA To Protect Hemp Industry

DISTRICT OF COLUMBIA: U.S. Senator Cory Gardner (R-CO) is calling on the U.S. Department of Agriculture (USDA) to delay implementation of the U.S. Domestic Hemp Production Program Interim Final Rule (IFR), which, as currently drafted, threatens the industrial hemp industry’s potential for Colorado’s farmers and seriously undermines this growing industry.

“The United States is now poised to transition from being a world-leading hemp importer to a world-leading hemp producer, and many look to Colorado farmers for guidance and clarity for the industry because Colorado is home to one of the longest-running state hemp programs,” wrote Senator Gardner. “I have worked with my colleagues and state officials to share with the USDA Colorado’s hemp experience, encourage greater flexibility for farmers, and encourage innovation of the industry. This includes echoing comments submitted by the State of Colorado during the IFR comment period.”

“I appreciate your leadership to the nation’s farmers throughout this extraordinary challenging time. Given these challenges, it is hard to overlook the great promise that the industrial hemp industry could provide to farmers if regulation is done in the proper manner. I encourage you to delay the final implementation of the IFR and work directly with state regulators and the industry to ensure workable rules that allow the industry to thrive,” Gardner concluded.

The full text of the letter can be found here and below:

Dear Secretary Perdue:

I write regarding the United States Department of Agriculture’s (USDA) U.S. Domestic Hemp Production Program Interim Final Rule (IFR), which, as currently drafted, threatens the industrial hemp industry’s potential for Colorado’s farmers and seriously undermines this burgeoning industry. I join the growing chorus of my colleagues, the National Association of State Departments of Agriculture, and the National Industrial Hemp Council in requesting that you use your secretarial discretion to delay implementation of the final rule in order to address several outstanding issues.

The nation’s hemp industry was given an enormous boost when hemp was de-scheduled in the Agriculture Improvement Act of 2018. The United States is now poised to transition from being a world-leading hemp importer to a world-leading hemp producer, and many look to Colorado farmers for guidance and clarity for the industry because Colorado is home to one of the longest-running state hemp programs. Since 2014, Colorado’s program has grown to include about 2,600 active registrations. In 2019, there were nearly 90,000 acres of registered hemp production in the state. Colorado farmers have been at the forefront of the hemp industry, driving change and innovation across the country. The state carefully balances regulatory oversight and economic support, allowing it to have a thriving industry and be a leader to other states.

I have worked with my colleagues and state officials to share with the USDA Colorado’s hemp experience, encourage greater flexibility for farmers, and encourage innovation of the industry. This includes echoing comments submitted by the State of Colorado during the IFR comment period. Despite my communications, there remain serious concerns about how the IFR will impact the Colorado industry.

I appreciate your leadership to the nation’s farmers throughout this extraordinary challenging time. Given these challenges, it is hard to overlook the great promise that the industrial hemp industry could provide to farmers if regulation is done in the proper manner. I encourage you to delay the final implementation of the IFR and work directly with state regulators and the industry to ensure workable rules that allow the industry to thrive.

Colorado Ag Department Provides State Hemp Plan Status Update

COLORADO:  The U.S. Department of Agriculture (USDA) has requested Colorado clarify and revise certain elements of its State Hemp Management Plan, submitted on June 18, 2020. The Colorado Department of Agriculture (CDA) is currently reviewing USDA’s comments and questions and considering revisions as it continues to prioritize representing the needs of the state’s industrial hemp registrants and stakeholders.

“As we have done from day one, CDA is working through the state plan submission and approval process in a careful and comprehensive manner to best serve the needs of Colorado,” said Colorado Commissioner of Agriculture Kate Greenberg. “Given the many changes at the federal level, we are working hard to create a stable and sound regulatory environment so that Colorado’s hemp industry can continue to lead the nation.”
Feedback received from numerous stakeholders statewide and over several months contributed to the plan, including input from farmers, processors and product manufacturers, state and local government agencies, healthcare professionals, financial services providers, law enforcement, and academic institutions, as well as consultation with Southern Ute and Ute Mountain Ute tribes, as part of CDA’s Colorado Hemp Advancement and Management Plan.

Colorado Legal Cannabis By The Numbers

COLORADO: How big is Colorado’s legal cannabis business?  According to statistics reported on the official Colorado State website, there are more than 460 medical marijuana grows, and more than 700 adult use cultivations in the Centennial State; with more than 1100 retail stores: 430 medical dispensaries and 700 recreational shops.

Here’s how the numbers break out:

Medical Marijuana Business License Numbers:

  • 466 Cultivations
  • 4 Delivery (Permits)
  • 7 Operators
  • 217 Product Manufacturers
  • 1 Research and Development and Research Cultivation
  • 439 Stores
  • 10 Testing Facilities
  • 7 Transporters

 Retail Marijuana Businesses License Numbers:

  • 703 Cultivations
  • 3 Hospitality
  • 9 Operators
  • 284 Product Manufacturers
  • 597 Stores
  • 11 Testing Facilities
  • 10 Transporters

Individual Licensees:

  • 1,732 Business Owners Licensees
  • 39,642 Employee Licensees

Nominations Sought for Colorado State Hemp Advisory Committee

COLORADO:The Colorado Department of Agriculture (CDA) is seeking member nominations for its Hemp Advisory Committee (HAC). The HAC advises the Department and confers on all matters regarding the regulation of hemp.

Committee members assist the Commissioner of Agriculture and program staff in promulgating rules to carry out the Hemp Act, Title 35, Article 61, and provide advice and consultation to the Commissioner and program staff by reviewing rules, recommending new rules or changes to existing rules. Members also offer advice and consultation on the establishment of an inspection program to determine THC concentration in compliance with the USDA Interim Final Rule and approved Colorado State Hemp Plan.

HAC members meet quarterly and serve two to three year terms. Members may be nominated to serve two successive terms. The committee is comprised of 10 members and there are a number of current openings. Specifically, nominations are sought for the following positions:

  • One member with experience in hemp regulation – to serve until July 31, 2021.
  • One member who is a farmer from a cooperative – to serve until July 31, 2022.
  • One member who is a commercial farmer – to serve until July 31, 2022.
  • One member with experience in seed development and genetics – to serve until July 31, 2022.
  • One representative from a research institution of higher education –  to serve until July 31, 2022.
  • One representative from the cannabinoid industry – to serve until July 31, 2021.

CDA welcomes nominations from those interested in serving from third party Hemp Associations. People from diverse constituencies and communities of color are encouraged to apply.

Applications are due August 31, 2020. The nomination form is available here. Please contact industrialhemp@state.co.us with questions and learn more about CDA’s industrial hemp program here.

Colorado Legal Cannabis By The Numbers 2/2020

COLORADO: Just how big is Colorado’s legal cannabis business?  Here are the official MED numbers, as of February, 2020.

2020 colorado cannabis nos

 

Medical Marijuana Business License Numbers:

  • 435 Centers
  • 462 Cultivations
  • 216 Infused Product Manufacturers
  • 11 Testing Facilities
  • 7 Operators
  • 7 Transporters
  • 1 Research and Development and Research Cultivation

 Retail Marijuana Businesses License Numbers:

  • 575 Stores
  • 680 Cultivations
  • 282 Product Manufacturers
  • 13 Testing Facilities
  •  9 Operators
  • 10 Transporters

Individual Licensees:

  • 1,712 Owners Licensees
  • 40,168 Employee Licensees

 

Colorado’s MedPharm Clears Significant DEA Hurdle For Federal Cannabis Research License

COLORADO: MedPharm Research, the leader in cannabis research and formulation development, was notified by the Drug Enforcement Administration (DEA) that it had been selected to move forward as one of the first applicants to be granted a license to grow federally legal cannabis under the terms of a new policy statement issued today in the Federal Register.

“This is something we have been waiting for since we first sent in our application in September, 2016, as one of the first medical grow facilities to apply for a license,” Albert Gutierrez, CEO of MedPharm, said. “Now, finally, the DEA has seen the importance of allowing federally legal grows to get more active in medical cannabis research, and do the work that we really need to do for patients across the country. It is a real game-changer for the whole medical cannabis industry.”

In a letter to Gutierrez, the DEA stated that MedPharm will be issued a Notice of Proposed Rule-making, where the company will be asked to comment on regulations about growing cannabis for medical research. However, the DEA has not provided a timetable for when those regulations will be completed. “We at MedPharm stand ready to assist the DEA in any way we can to help expedite this process, and bring to patients the best quality, FDA-approved cannabis that they need for research and treatment as quickly as possible,” said Gutierrez.

According to the University of Mississippi News, in 1968, the Research Institute of Pharmaceutical Sciences at the University of Mississippi School of Pharmacy was awarded a competitive contract from the government to grow marijuana that could be standardized for research. For over 50 years, it has remained the only cultivation facility licensed by the DEA to provide federally legal cannabis for medical researchers, who have reported that cannabis from the university is of such poor quality that it is essentially useless in conducting the lab work and human trials necessary for a reliable FDA-approved medical research.

As more medical cannabis research ramped up, a growing group of medical cannabis researchers pressured the DEA to open up licensing to other facilities. Then, in August, 2016, the DEA stated that they would begin accepting applications for companies wanting licenses for legal grows, but nothing more happened until this June, when one of the applicants sued the DEA for unreasonable delays, prompting today’s response.

MedPharm is well-positioned to work with the DEA and be among the first providers of federally legal cannabis for medical research. The application for the license included outlining research objectives and creating areas where medical research cannabis is grown specifically for research purposes.

First US Clinical Study Assessing Hemp-Derived Cannabinoid Supplementation In Recovery From Traumatic Brain Injury Begins In Colorado

COLORADO:  The Flowering HOPE Foundation and Clover Leaf University have just announced sponsorship and collaboration on the first US clinical study to be approved to investigate plant-derived cannabinoid supplements in recovery from brain injury. 

The study will analyze quantitative EEG brain activity and a cannabinoid-sensitive salivary biomarker in 40 subjects with mild traumatic brain injury and controls who currently take hemp-derived botanical supplements on a regular basis (i.e. phytocannabinoids). The study is recruiting adults age 18 to 55 to participate in the year-long trial. 

Jason Cranford, Founder of the Flowering HOPE Foundation, a Colorado registered 501(c)(3) nonprofit organization that supports the medicinal use of plant-derived cannabinoids, called phytocannabinoids, described the motivation for sponsoring the study: “We hope to provide scientific support for the benefits of the natural plant-based compounds contained in hemp and move a step closer towards the unrestricted availability of non synthetic cannabinoid therapeutics.”

Cranford is a pioneer in the emerging cannabis industry with more than 25 years experience in cultivation, extraction and formulations. His know-how allowed him to breed a unique hemp strain selected for a blend of phytoterpenes and phytocannabinoids designed to alleviate treatment-resistant epilepsy in children without psychoactive side effects. The resulting strain, called Haleigh’s Hope, was formulated into a supplement offered by the FHF (2013). 

The FHF has partnered with Clover Leaf University to study brain injury. The President and Founder, Chloe Villano, received accredited approval for CLU in 2013 by the Colorado Department of Higher Education’s Private Occupational School Board. Villano is a pioneer in the cannabis and hemp industry and prioritized brain injury for the study.

“This historic study is the first of its kind and it is a privilege to work with the Flowering HOPE Foundation to address the problem of brain injury and collaborate with a neuroscientist who understands the brain endocannabinoid system, such as Dr. Cooper. There are currently no effective treatments for traumatic brain injury or chronic traumatic encephalopathy, but phytocannabinoids may be a good candidate, based on the established science of anti-inflammatory and neuroprotective mechanisms. Clover Leaf University is excited to take the lead in clinical studies that will improve and save lives,” said Villano.

The lead neuroscientist responsible for the study,  Don Cooper, Ph.D, is President of Real-Time Diagnostics Ventures Inc. He has published 45 peer reviewed papers on neuronal memory formation/plasticity and has studied brain cannabinoids since 2000, when he received his first NIH grant. 

“I never thought it would take almost 20 years from when I started working on the brain cannabinoid system to have the first approved clinical study on phytocannabinoids and brain injury. We have convincing preclinical data showing that phytocannabinoids are neuroprotective and may be critically important for restoring neuronal function after brain injury,” stated Cooper.

For more information contact the study Clinical Coordinator at TBIstudy@protonmail.com.

Colorado’s Legal Cannabis Industry: By The Numbers

COLORADO: How big is Colorado’s legal cannabis industry? According to the Colorado Department of Revenue Enforcement Division, there are 675 medical marijuana cultivators supplying 239 infused product manufacturers, with 735 cultivators supplying 549 retail stores in Colorado.

Here are the official numbers as of January 2, 2019.

Colorado Cannabis By the numbers

Source: MED Resources & Statistics 

CDA Announces Colorado’s 2018 CDA-Approved Certified Hemp Seed Varieties

CDA-LogoCOLORADO: The Colorado Department of Agriculture (CDA) is announcing that six industrial hemp seed varieties have passed the 2018 statewide THC validation and observation trial and are now eligible to be grown by the members of the Colorado Seed Growers Association for production of “CDA Approved Certified Seed.”

In 2018, the CDA Approved Certified Hemp seed program trialed eight varieties of hemp across Colorado’s diverse growing conditions to validate if they would grow mature plants that test at or below 0.3% THC concentration on a dry weight basis. During 2018, the program approved six new varieties approved to be grown as a class of “CDA Approved Certified Seed.”
CDA Hemp Seeds
To be CDA Approved Certified Seed, hemp varieties must be produced and labeled by members of the Colorado Seed Growers Association according to Association of Official Seed Certifying Agencies (AOSCA) standards.
The seed varieties were grown and tested in the Northeast, Arkansas Valley, Front Range, the San Luis Valley and on the Western Slope.  These five locations with distinct differences in daytime and nighttime temperatures, in altitude, length of growing season, and soil types, provide the CDA with a broad representation of Colorado’s growing conditions. Growers planting with CDA Approved Certified Seed would be considered very low risk for testing purposes.
For seed availability please contact the seed companies listed. The CDA Approved Certified Seed program requires that all individual seed packages be tagged with both CDA tags and certified seed tags. CDA does not sell seed and has no information about seed availability or variety performance; please check with the individual seed companies listed.
CDA Approved Varieties to Date
For more information on the certified seed program, visit the CDA’s Industrial Hemp web page or contact Terry Moran, Industrial Hemp Certified Seed Specialist, at 303.869.9078 or email Terry.moran@state.co.us.